Synaptogenix Pre-Tax Profit Margin 2020-2025 | TAOX
Synaptogenix pre-tax profit margin from 2020 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Synaptogenix Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.012B |
$0.000B |
|
Synaptogenix Inc. is an emerging biopharmaceutical company. It focused on developing therapies for neurodegenerative diseases. The company's lead therapeutic candidate consist Bryostatin-1. Synaptogenix Inc. is based in NEW YORK.
|
